SCY-247, a novel second-generation IV/oral triterpenoid antifungal, is efficacious in the neutropenic mouse model of pulmonary mucormycosis
Evaluation of in vitro Activity, Cytotoxicity, and in vivo Efficacy of Novel Liposomal Formulations of Amphotericin B in Comparison to Natamycin and Liposomal Amphotericin B (AmBisome) in a Murine Model of Experimental Mycotic Keratitis caused by Aspergillus fumigatus
Fighting Aspergillus infection using biocontrol bacteria: A proof of concept study for environmental interference in a translational setting
In vivo antifungal screening against triazole-resistant and -susceptible Aspergillus fumigatus using bioluminescence imaging in Galleria mellonella
Efficacy assessment of SF001, A 3rd generation polyene antifungal, in the neutropenic mouse model of invasive pulmonary aspergillosis and mucormycosis
Can polymeric particles potentially deliver antifungals inside phago(lyso)somes containing intracellular persistent conidia of Aspergillus fumigatus?